<unk>  is a gastrointestinal agent that is FDA approved for the treatment of exocrine pancreatic insufficiency due to cystic fibrosis, chronic pancreatitis, pancreatectomy, or other conditions.   Common adverse reactions include vomiting, dizziness, cough, hyperglycemia, hypoglycemia, abdominal pain, abnormal feces, flatulence, frequent bowel movements, and nasopharyngitis.
Pancrelipase
Bemiparin
Ticagrelor
Reteplase
Tenecteplase
Alteplase 
Ticlopidine
Guanadrel